FDG-PET sheds light on survival in non-small cell lung cancer

04/10/2013 | MedPage Today (free registration)

Positive results on an FDG-PET scan may indicate poorer survival in patients with early-stage non-small cell lung cancer, according to findings presented at a cancer research meeting. Patients with the positive PET scan showed a median five-year survival of 67%, while survival for those with negative results was 80%. The method may help determine which patients should have adjuvant chemotherapy, researchers said.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL